AlphaCentric Advisors LLC Has $67,000 Stake in Cardinal Health, Inc. (NYSE:CAH)

AlphaCentric Advisors LLC trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 14.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 564 shares of the company’s stock after selling 96 shares during the period. AlphaCentric Advisors LLC’s holdings in Cardinal Health were worth $67,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of CAH. MWA Asset Management raised its position in shares of Cardinal Health by 2.9% in the 4th quarter. MWA Asset Management now owns 3,324 shares of the company’s stock valued at $393,000 after acquiring an additional 95 shares during the period. Huntington National Bank raised its holdings in Cardinal Health by 0.9% in the third quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after purchasing an additional 100 shares during the period. Frazier Financial Advisors LLC boosted its position in shares of Cardinal Health by 69.8% during the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares in the last quarter. Raleigh Capital Management Inc. grew its holdings in shares of Cardinal Health by 29.6% in the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock valued at $55,000 after buying an additional 106 shares during the period. Finally, Patron Partners LLC increased its position in shares of Cardinal Health by 6.1% in the 4th quarter. Patron Partners LLC now owns 2,043 shares of the company’s stock valued at $242,000 after buying an additional 117 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

NYSE:CAH opened at $126.35 on Tuesday. The stock’s 50-day simple moving average is $122.95 and its 200 day simple moving average is $116.57. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84. The company has a market cap of $30.52 billion, a P/E ratio of 23.57, a P/E/G ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is currently 37.69%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on CAH shares. Deutsche Bank Aktiengesellschaft boosted their target price on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Morgan Stanley boosted their price objective on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, January 31st. JPMorgan Chase & Co. increased their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Barclays lifted their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Finally, Jefferies Financial Group raised shares of Cardinal Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $136.87.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.